• No se han encontrado resultados

Esteroides Nebulizados

N/A
N/A
Protected

Academic year: 2020

Share "Esteroides Nebulizados"

Copied!
11
0
0

Texto completo

Loading

Figure

Cuadro 1: Diferencias entre el mecanismo  genómico y no genómico de los GCS.

Referencias

Documento similar

Abstract: We systematically reviewed the current knowledge on fixed-dose triple therapies for the treatment of chronic obstructive pulmonary disease (COPD), with a specific focus

The budget impact of Duoresp ® Spiromax ® (budesonide+ formoterol fumarate dihydrate) compared with Symbicort ® Turbohaler ® for the management of asthma and chronic

El cáncer tiene un origen complejo, sin embar- go, las alteraciones que se presentan en la EPOC, como la activación de factores de crecimiento tró- fico y vascular, así como

Se concluye que la alta prevalencia y subdiagnóstico de enfermedad pulmonar obstructiva crónica, la convierten en un importante problema de salud en La Habana Cuba.. Se

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary

recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat

Patients with IE in the latter period of the study were older, more likely to have higher Charlson index, hypertension, heart failure, chronic obstructive pulmonary disease,

PROMISE: Predicting Outcome using Systemic Markers in Severe Exacerbations of Chronic Obstructive Pulmonary Disease; BODE: body mass index, airflow obstruction, dyspnoea,